Evaluating the Effectiveness of ChemoNurs: A Mobile Chemotherapy Drug Guide for Oncology Nurses

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

59 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-08-01

Study Completion Date

2025-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aimed to evaluate the effectiveness of a mobile chemotherapy drug guide application, ChemoNurs, developed for oncology nurses, in improving their knowledge and attitudes toward chemotherapy practices.

H1: The mobile chemotherapy drug guide developed for oncology nurses increases their knowledge related to chemotherapy.

H2: The mobile chemotherapy drug guide developed for oncology nurses promotes the development of positive attitudes toward chemotherapy.

H3: The mobile chemotherapy drug guide developed for oncology nurses increases their satisfaction.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effects of Symptom Management Education With Mobile Application in Gynecological Cancer Patients Receiving Chemotherapy

NCT06713122

Gynaecological Cancer Chemotherapy Nursing Care

ENROLLING_BY_INVITATION NA

The Effect of Mobile Application-Assisted Nursing Services on Symptom Control in Breast Cancer Patients

NCT07200791

Symptom Management Quality of Life

NOT_YET_RECRUITING NA

The Effect of Patient Education Given by Teach-Back Method on Managing Chemotherapy Symptoms

NCT05825287

Teach-Back Communication

COMPLETED NA

Telenursing and Breast Cancer: The Turkish Case

NCT04480229

Breast Cancer Female

COMPLETED NA

The Effect of Education Provided With Pecha Kucha Method on Cancer Patients Receiving Chemotherapy on Symptom Management and Quality of Life

NCT05701930

Symptom Management Life Quality

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chemotherapy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Outcome Assessors

An independent statistician and a doctoral student working as a research assistant were responsible for the randomization and group assignment processes. Their involvement ensured the systematic conduct of the study and helped control selection bias through randomized allocation and allocation concealment. Due to the researcher's awareness of the intervention, blinding during the implementation phase was not feasible.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Application Group

Participants in the experimental group were oncology nurses employed at Hacettepe University Oncology Hospital who were provided access to CHEMONURS, a mobile chemotherapy drug guide application developed to support clinical decision-making and professional development. After completing a demographic form and baseline assessments using the Chemotherapy Practice Knowledge Scale and the Attitude Scale for Chemotherapy Practices, participants received a demo version of the app via a WhatsApp link. They were instructed to download the application onto their personal smartphones and use it freely over a six-month period during their routine clinical practice. No restrictions were placed on usage frequency to reflect real-world applicability; usage was monitored through embedded app analytics and nurse feedback. Daily reminders and follow-up communications were used to encourage continued engagement. Follow-up assessments of knowledge and attitudes were conducted at the 3rd and 6th months.

Group Type EXPERIMENTAL

ChemoNurs Mobile Application Group

Intervention Type OTHER

Participants in the mobile app group were oncology nurses employed at Hacettepe University Oncology Hospital who were provided access to CHEMONURS, a mobile chemotherapy drug guide application developed to support clinical decision-making and professional development. After completing a demographic form and baseline assessments using the Chemotherapy Practice Knowledge Scale and the Attitude Scale for Chemotherapy Practices, participants received a demo version of the app via a WhatsApp link. They were instructed to download the application onto their personal smartphones and use it freely over a six-month period during their routine clinical practice. No restrictions were placed on usage frequency to reflect real-world applicability; usage was monitored through embedded app analytics and nurse feedback. Daily reminders and follow-up communications were used to encourage continued engagement. Follow-up assessments of knowledge and attitudes were conducted at the 3rd and 6th months. U

Personal Smartphone

Intervention Type DEVICE

Used by participants to access and interact with the CHEMONURS mobile application during the study period.

Standard Practice

Participants in the control group were oncology nurses working at Hacettepe University Oncology Hospital who continued with their routine clinical duties without access to the CHEMONURS mobile application or any additional educational intervention. After completing the baseline assessment using the Chemotherapy Practice Knowledge Scale and the Attitude Scale for Chemotherapy Practices, no further intervention was provided. Follow-up assessments of knowledge and attitudes were conducted at the 3rd and 6th months, in parallel with the experimental group, to evaluate changes over time in the absence of the mobile application.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ChemoNurs Mobile Application Group

Participants in the mobile app group were oncology nurses employed at Hacettepe University Oncology Hospital who were provided access to CHEMONURS, a mobile chemotherapy drug guide application developed to support clinical decision-making and professional development. After completing a demographic form and baseline assessments using the Chemotherapy Practice Knowledge Scale and the Attitude Scale for Chemotherapy Practices, participants received a demo version of the app via a WhatsApp link. They were instructed to download the application onto their personal smartphones and use it freely over a six-month period during their routine clinical practice. No restrictions were placed on usage frequency to reflect real-world applicability; usage was monitored through embedded app analytics and nurse feedback. Daily reminders and follow-up communications were used to encourage continued engagement. Follow-up assessments of knowledge and attitudes were conducted at the 3rd and 6th months. U

Intervention Type OTHER

Personal Smartphone

Used by participants to access and interact with the CHEMONURS mobile application during the study period.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Actively administering chemotherapy treatments
* Having knowledge of how to use an Android or iOS smartphone
* Possessing mobile literacy
* Working in oncology clinics for a duration of 0-12 months
* Volunteering to participate in the study

Exclusion Criteria

* Not having completed the orientation process in oncology clinics
* Not having administered chemotherapy
* Incomplete responses in the data collection forms
* Willingness to withdraw at any stage of the study
* Participation in the Oncology Nursing Certification Program
* Prior attendance in courses or training sessions related to chemotherapy drugs

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes